GENE ONLINE|News &
Opinion
Blog

Editors' Picks
ESG & Sustainability in Healthcare
The Weight of Care: How Healthcare Became One of the Planet’s Largest Emitters
2026-07-08
BIO Asia–Taiwan 2026 Preview: AI Drug Discovery, CDMO and CGT Take Center Stage
2026-07-07
ESG & Sustainability in Healthcare
The Green Lab: Rethinking Research from the Bench Up
2026-07-08
ESG & Sustainability in Healthcare ESG
Medical Device Manufacturing Shifts Toward Green Additive Production and Circular Economy Models
In the current regulatory climate, the intersection of Environmental, Social, and Governance (ESG) mandates and technological innovation has transitioned from a voluntary disclosure exercise to …

Home Read More »

2026-07-08
Trials & Approvals FDABlood CancerCell TherapyTransplant
FDA Approval Marks New Era for Precision Cell Therapy in Blood Cancer Transplants
2026-07-08
Advanced Biologics & Biosimilars
Advanced Biologics & Biosimilars HanchorBioHCB101
HanchorBio and InxMed Explore “Barrier Disruption + Myeloid Activation” Strategy for Difficult-to-Treat Solid Tumors
On July 8, 2026, FDB Biologics Limited, a subsidiary of HanchorBio, signed a strategic memorandum of understanding (MoU) with InxMed (Shanghai) Co., Ltd. At first …

HanchorBio and InxMed Explore “Barrier Disruption + Myeloid Activation” Strategy for Difficult-to-Treat Solid Tumors Read More »

2026-07-08
EirGenix
EirGenix Signs Licensing and Commercialization Agreement with Japanese Pharmaceutical Company for EG1206A in Japan
Taipei, June 29 — EirGenix Inc. (TWSE: 6589) has signed a global exclusive licensing agreement with Sandoz AG for the commercialization of its independently developed …

EirGenix Signs Licensing and Commercialization Agreement with Japanese Pharmaceutical Company for EG1206A in Japan Read More »

2026-07-02
Honeybear Biosciences Bringing Total Funds Raised to $34 Million to Accelerate Lead Radiopharmaceutical Candidates into Clinical Trial
Honeybear Biosciences Inc. announces the completion of a US $20 million Series A financing round, bringing the total capital raised to US$34 million, making it …

Honeybear Biosciences Bringing Total Funds Raised to $34 Million to Accelerate Lead Radiopharmaceutical Candidates into Clinical Trial Read More »

2026-06-30
LATEST
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Penn State College of Medicine Receives $2.5 Million Grant for Street Medicine Program
2026-07-10
IBEC and European Researchers Receive Novo Nordisk Foundation Grant to Study Physics of Living Matter
2026-07-10
READ MORE
Markets & Deals
AI, Tech & Digital Innovation
US BIO 2026 AI Drug Discovery
Biopharma Leaders Confront Operational Realities and Data Hurdles at BIO 2026 AI Summit
2026-07-02
AI-Powered Blood Test Accurately Classifies Multiple Neurodegenerative Diseases And Detects Co-Existing Conditions
2026-06-06
The Island That Builds AI: Inside NVIDIA GTC Taipei and How Taiwan Became the World’s Most Critical Technology Ecosystem
2026-06-01
Cell, Gene & Regen Therapies
Cell, Gene & Regen Therapies Tang PrizeCAR T-cell Therapy
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
Breakthrough RNA Segment Editing Technology Offers New Hope for Treating Neurodegenerative Diseases
2026-06-05
German Rare Disease Diagnostics Firm CENTOGENE Moves Closer to Asia’s Frontlines With Taiwan HQ
2026-05-22
Discovery
AI Drug Discovery
AI-designed Drug Rentosertib Advances Into Phase III Trial for Idiopathic Pulmonary Fibrosis
2026-07-08
FDA Approval Marks New Era for Precision Cell Therapy in Blood Cancer Transplants
2026-07-08
Honeybear Biosciences Bringing Total Funds Raised to $34 Million to Accelerate Lead Radiopharmaceutical Candidates into Clinical Trial
2026-06-30
Ranking & Reports
Ranking & Reports
Oncology Trends ASCO 2026
10 Small-Cap Cancer Tickers: What They Promised, What They Delivered
2026-06-22
The Cancer Drugmakers Pulling Ahead—and What They’re Building Next
2026-06-22
5 FDA First-in-Class Approvals in 2026: New Mechanisms, New Modalities, New Markets
2026-05-21
VIDEOS
Rakuten Medical’s Alluminox™: How Light and Precision are Changing the Standard of Cancer Care
01:02
Rakuten Medical’s Alluminox™: How Light and Precision are Changing the Standard of Cancer Care
As Rakuten Medical’s President Minami Maeda puts it: “Innovation isn’t ...
Dr. Gur Roshwalb on How Biotech Startups Can Survive Venture Capital Realities
01:45
Dr. Gur Roshwalb on How Biotech Startups Can Survive Venture Capital Realities
Early-stage biotech companies face a paradox. They drive the ...
“To Conquer Cancer with Light” — Minami M., President of Rakuten Medical
15:48
“To Conquer Cancer with Light” — Minami M., President of Rakuten Medical
“To Conquer Cancer with Light” — Minami M., President of Rakuten ...
Moderna’s mRNA Next Act: Cancer, RSV & Rare Diseases
01:58
Moderna’s mRNA Next Act: Cancer, RSV & Rare Diseases
In this interview, we dive into Moderna’s evolving strategy with ...
Dr. Wafa Samara on Pharmacy’s Evolving Strategic Role
02:01
Dr. Wafa Samara on Pharmacy’s Evolving Strategic Role
In this interview, Dr. Wafa Samara explores how pharmacy is evolving ...
Fighting Alzheimer’s by Reversing Brain Aging and Boosting Resilience
02:29
Fighting Alzheimer’s by Reversing Brain Aging and Boosting Resilience
Dr. Tseng, CEO of Acroviz breaks down the science behind “brain age” ...
The 3 Pillars of Taiwan Biotech
12:29
The 3 Pillars of Taiwan Biotech
TK Li showcases how integrating medicine, technology, and food creates ...
DCB, FIRDI & ITRI Spotlight Breakthrough Biotech at BIO Asia–Taiwan
05:54
DCB, FIRDI & ITRI Spotlight Breakthrough Biotech at BIO Asia–Taiwan
At the BIO Asia–Taiwan 2025, GeneOnline visited the pavilions of the ...
Inside 2025 BIO Asia-Taiwan CMU Pavilion: Breakthroughs in CAR-T, Exosomes & Antibodies
08:59
Inside 2025 BIO Asia-Taiwan CMU Pavilion: Breakthroughs in CAR-T, Exosomes & Antibodies
At the 2025 BIO Asia–Taiwan, GeneOnline visited the China Medical ...
New DDB2-Targeting Strategy for Metastatic TNBC by CMU
New DDB2-Targeting Strategy for Metastatic TNBC by CMU
GeneOnline sat down with Hsin-Chiao Chou (Ilsa Chou), Postdoctoral ...
CytoArm CEO on Next-Gen Solid Tumor Immunotherapy
CytoArm CEO on Next-Gen Solid Tumor Immunotherapy
While CAR-T therapies have revolutionized treatment for blood cancers, ...
PlasmonicTron CEO on Retinal Organoid Innovation
00:29
PlasmonicTron CEO on Retinal Organoid Innovation
With aging populations worldwide, degenerative eye diseases like ...
Australia Pavilion Showcases Clinical Trial Excellence at BIO Asia
00:37
Australia Pavilion Showcases Clinical Trial Excellence at BIO Asia
At BIO Asia–Taiwan 2025, the Australia Pavilion brought together 24 ...
Phoenix Rising as a Global Health-Tech Hub
06:53
Phoenix Rising as a Global Health-Tech Hub
Phoenix is emerging as one of the most compelling stories in the ...
Scaling Medtech Startups Globally: Insights from Experts
Scaling Medtech Startups Globally: Insights from Experts
“What doctors want isn’t always what hospitals buy or what insurers ...
BIO Asia–Taiwan 2025: Taiwan’s Global Biotech Showcase
BIO Asia–Taiwan 2025: Taiwan’s Global Biotech Showcase
BIO Asia–Taiwan 2025 is just around the corner, returning to Taipei ...
ITRI Advances Ophthalmology and Cell Therapy Innovations
05:41
ITRI Advances Ophthalmology and Cell Therapy Innovations
In an interview with GeneOnline during BIO International Convention ...
AP Biosciences’ Dual Platforms for Cancer Immunotherapy
AP Biosciences’ Dual Platforms for Cancer Immunotherapy
In an interview with Spike Lo at BIO International Convention 2025, ...
BioMap CEO Wei Liu on AI Drug Discovery
02:46
BioMap CEO Wei Liu on AI Drug Discovery
Wei LIU, CEO of BioMap, points out that while AI is accelerating ...
Hong Kong’s Bold Push to Transform Global Health: Biotech, Medtech, and Beyond
01:18
Hong Kong’s Bold Push to Transform Global Health: Biotech, Medtech, and Beyond
The global health landscape faces intense pressure: aging populations, ...
Categories
Interviews
Interviews
Metabolomics vs Genetics: Looking Beyond Inherited Risk
2026-07-07
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
Development to Market
Intelligence
Biotech Layoffs in 2026: Trends, Triggers, and What’s at Stake
2026-07-07
AbbVie Acquires Apogee Therapeutics for $10.9 Billion to Bolster Immunology and Respiratory Pipeline
2026-06-23
The Cancer Drugmakers Pulling Ahead—and What They’re Building Next
2026-06-22
Trials & Approvals
AI Drug Discovery
AI-designed Drug Rentosertib Advances Into Phase III Trial for Idiopathic Pulmonary Fibrosis
2026-07-08
FDA Approval Marks New Era for Precision Cell Therapy in Blood Cancer Transplants
2026-07-08
Honeybear Biosciences Bringing Total Funds Raised to $34 Million to Accelerate Lead Radiopharmaceutical Candidates into Clinical Trial
2026-06-30
APAC
EirGenix
EirGenix Signs Licensing and Commercialization Agreement with Japanese Pharmaceutical Company for EG1206A in Japan
2026-07-02
Arizona and Taiwan Sign MOU to Foster Bilateral Biotech Exchange and Collaboration
2026-06-26
New Epigenetic Approach Revives Exhausted Immune Cells to Enhance Cancer Immunotherapy Outcomes
2026-06-18
Exosomes & Delivery
Pandorum Partners With Nucelion to Scale Exosome-Based Eye Therapies Across Asia-Pacific
2026-01-08
Taiwan’s Biotech Bet: DCB’s Role in Advancing Exosome Therapy
2025-05-22
GO PRIME
A Closer Look at EV-Based Therapeutics: Purification, Scalability, and GMP Compatibility
2025-05-06
GO PRIME
Manufacturing & Logistics
Conference global biotech supply chain
Can Global Healthcare Systems Stay Resilient Without Reinventing Pharmaceutical Manufacturing?
2026-05-20
Hong Kong Turns Healthcare Into Industrial Strategy at ASGH 2026
2026-05-11
EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan
2026-04-28
Innovation & Entrepreneurship
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Why Rare Disease Drugmakers Are Building Regional Strategies Instead of Global Ones
2026-06-01
Protuoso Biosciences Launches with $9.5M to Pioneer AI-Driven “Hub-and-Spoke” Biologics Development
2026-05-27
Infection, Immunity & Vaccination
Public Health Infectioninfection control
Cruise Ship Hantavirus Outbreak Revives COVID-19 Era Fears as WHO Says Public Risk Remains Low
2026-05-13
Nipah Virus Resurgence in South Asia: Health Authorities Ramp Up Surveillance Amid Fresh Outbreak Fears
2026-01-29
GO PRIME
Viral Defense 2.0: How Long-Acting Biologics and Startups are Reimagining the Flu Season
2026-01-20
GO PRIME
Neuroscience & Mental Health
The Next Era of Brain Disease Will Be Built on Prevention and Combination Therapies
2026-07-03
The Architects of Memory and Movement: Who Is Building the Future of Brain Disease Treatment
2026-06-29
GO PRIME
Insilico Medicine and SK Biopharmaceuticals Announce Up to $2.5 Billion AI Neuroimmune Drug Collaboration
2026-06-22
EVENT
2026-07-08
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
2026-07-15
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
SEE MORE
Scroll to Top